THE EFFECT OF A 5HT 2 RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET FUNCTION IN BUERGER'S DISEASE

Author： Rydzewski A. Urano T. Hachiya T. Kaneko H. Baba S. Takada Y. Takada A.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.84, Iss.6, 1996-12, pp. : 445-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Sarpogrelate, a 5-HT_2A Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study

Cerebrovascular Diseases, Vol. 24, Iss. 2-3, 2007-07 ,pp. : 264-270

Karger

Access to resources Recommend Favorite

Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT 2 antagonist (SR46349).

By Li Hui Y. Callas D. Fareed J. Herbert J.M.

Thrombosis Research, Vol. 81, Iss. 5, 1996-03 ,pp. : 555-567

Elsevier

Access to resources Recommend Favorite

Effects of Tropisetron, a 5-HT₃ Receptor Antagonist, on Proximal Gastric Motor and Sensory Function in Nonulcer Dyspepsia

Digestion, Vol. 60, Iss. 2, 1999-03 ,pp. : 147-152

Karger

Access to resources Recommend Favorite

Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

By Johnson Fred L. Boyer José L. Leese Philip T. Crean Christopher Krishnamoorthy Ramesh Durham Todd Fox Anthony W. Kellerman Donald J.

Platelets, Vol. 18, Iss. 5, 2007-08 ,pp. : 346-356

Informa Healthcare

Access to resources Recommend Favorite

A Potent 5-Hydroxytryptamine Receptor (5-HT2A) Antagonist, DV-7028, Delays Arterial Thrombosis Development in Rats - Inhibition of the serotonergic component by ketanserin

By Pawlak D. Pawlak K. Chabielska E. Malyszko J. Takada A. Mysliwiec M.x. Buczko W.x.

Thrombosis Research, Vol. 90, Iss. 6, 1998-06 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite